NCT04842630 2024-02-09A Phase 1 Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid TumorsJiangsu HengRui Medicine Co., Ltd.Phase 1 Terminated11 enrolled